SPONSOR
Xiangdong Cheng
Total Trials
3
Recruiting
3
Phases
Phase 1, Phase 2, Phase 2
Conditions studied: Gastric CancersEsophagogastric Junction CancersImmune SuppressionGastric CancerAdvanced Gastric CarcinomaAdvanced Gastroesophageal Junction Adenocarcinoma
Xiangdong Cheng is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Gastric Cancers, Esophagogastric Junction Cancers, Immune Suppression, Gastric Cancer.
The trial portfolio spans Phase 1, Phase 2, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Xiangdong Cheng
How many clinical trials has Xiangdong Cheng sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Xiangdong Cheng, of which 3 are actively recruiting participants. These trials cover conditions including Gastric Cancers, Esophagogastric Junction Cancers, Immune Suppression. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Xiangdong Cheng research focus on?
Xiangdong Cheng clinical trials span Gastric Cancers, Esophagogastric Junction Cancers, Immune Suppression, Gastric Cancer, Advanced Gastric Carcinoma, and additional conditions. The research pipeline includes Phase 1, Phase 2, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Xiangdong Cheng clinical trial?
To participate in a Xiangdong Cheng trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Xiangdong Cheng trials with current recruitment status updated daily.
Clinical Trials by Xiangdong Cheng
NCT06766305 Phase 1, Phase 2
Recruiting
QL1706 Combined With SOX Used in Theperioperative Treatment
Gastric Cancers
NCT05739045 Phase 2
Recruiting
Nivolumab Combined With SOX Used in the Perioperative Treatment
Immune Suppression
NCT06642857
Recruiting
Multi-omics Based Prediction of Treatment Response to Immunotherapy Combined with Chemotherapy in Advanced Gastric/Gastroesophageal Junction Cancer.
Advanced Gastric Carcinoma
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology